Investors
Don't miss any news, subscribe to our press releases.
Extraordinary General Meeting 2021
Extraordinary General Meeting in Sprint Bioscience AB (publ)
(The full text of the invitation can be found in Press releases and as an annex on this page)
The shareholders of Sprint Bioscience AB (publ), corporate identity number 556789-7557 ("Sprint Bioscience" or "The Company"), are hereby invited to the Extraordinary General Meeting on 21 July 2021.
In light of the risk of spreading Covid-19 and the authorities' regulations and advice on avoiding gatherings, the Board of Directors has decided, on the basis of temporary legal provisions, that the meeting will be conducted without physical presence by shareholders exercising their voting rights only by postal voting.
Information on the resolutions adopted by the General Meeting will be published on 21 July 2021 through a press release.
Right to participate in the General Meeting
Shareholders who wish to attend the meeting shall:
- be entered in the share register maintained by Euroclear Sweden AB no later than 13 July 2021, and
- notify their participation no later than 20 July 2021 by submitting a complete postal voting form and, where applicable, proxies, registration certificates and other corresponding authorisation documents in accordance with the instructions under the heading "Information on postal voting" below.
Shareholders whose shares are registered in the name of a nominee through a bank or securities institution must temporarily re-register the shares in their own name in order to be entitled to participate in the meeting. Such registration must be completed with Euroclear Sweden AB on 15 July 2021, which means that the shareholder must inform the nominee well in advance of this date.
Information on postal voting
Postal voting procedure
The shareholders may exercise their voting rights at the general meeting only by voting in advance, so-called postal voting, in accordance with section 22 of the Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations.
A special form shall be used for the postal vote. The form will be available on the Company's website (www.sprintbioscience.comThe postal voting form is valid as registration for the General Meeting.
The completed form must be received by the Company no later than 17 July 2021. The form can be sent by post to Sprint Bioscience AB (publ), Novum, Hälsovägen 7, 141 57 Huddinge or send an e-mail to info@sprintbioscience.com.
A postal vote can be withdrawn until 20 July 2021 by email or post to the above addresses. If two or more forms have the same date, only the form received last will be taken into account.
Shareholders may not attach special instructions or conditions to the postal vote. If this happens, the vote (i.e. the postal vote as a whole) is invalid. Further instructions are provided in the postal voting form.
In the postal voting form, shareholders may request that resolutions on one or more of the matters on the proposed agenda as set out below be postponed to a so-called continued general meeting, which may not be a pure postal voting meeting. Such continued general meeting shall take place if the general meeting so resolves or if holders of at least one tenth of all shares in the Company so request.
Postal voting by proxy
Shareholders who vote by proxy must issue a written authorisation signed and dated by the shareholder for the proxy. If postal voting is carried out by proxy, the proxy shall be attached to the postal voting form. If the power of attorney is issued by a legal entity, a copy of the registration certificate must also be attached to the postal voting form or, if such document does not exist, the corresponding authorisation document. Proxy forms for shareholders who wish to vote by proxy will be available on the Company's website (www.sprintbioscience.com).